Literature DB >> 15702035

Varicella-zoster virus reactivation is an important cause of acute peripheral facial paralysis in children.

Yasushi Furuta1, Fumio Ohtani, Hiroshi Aizawa, Satoshi Fukuda, Hiroki Kawabata, Tomas Bergström.   

Abstract

BACKGROUND: Reactivation of herpes simplex virus type 1 is thought to be a major cause of adult idiopathic peripheral facial paralysis or Bell's palsy. However, few studies have examined the pathogenesis of this condition in children. Serologic assays and polymerase chain reaction (PCR) analysis of paired sera and saliva samples were used here to investigate the causes of acute peripheral facial paralysis in pediatric patients.
METHODS: A total of 30 children with acute peripheral facial paralysis were recruited. Paired sera were assayed for evidence of herpesvirus, mumps virus or Borrelia infection. PCR was used to detect herpes simplex virus type 1 and varicella-zoster virus (VZV) DNA in saliva samples.
RESULTS: Ramsay Hunt syndrome with accompanying zoster lesions was diagnosed clinically in 2 patients, and VZV reactivation was confirmed serologically. VZV reactivation in the absence of zoster (zoster sine herpete) was diagnosed in 9 patients with either serologic assays or PCR. Thus VZV reactivation was demonstrated in 11 of 30 (37%) patients. The prevalence of VZV reactivation among patients between 6 and 15 years of age was significantly higher than in those younger than 5 years of age (53% versus 9%, P = 0.023).
CONCLUSIONS: Our data indicate that VZV reactivation is an important cause of acute peripheral facial paralysis in children, especially those between 6 and 15 years of age.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15702035     DOI: 10.1097/01.inf.0000151032.16639.9c

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  16 in total

1.  Complete-genome phylogenetic approach to varicella-zoster virus evolution: genetic divergence and evidence for recombination.

Authors:  Peter Norberg; Jan-Ake Liljeqvist; Tomas Bergström; Scott Sammons; D Scott Schmid; Vladimir N Loparev
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

2.  The history and mystery of VZV in saliva.

Authors:  Anne A Gershon
Journal:  J Infect Dis       Date:  2011-09-15       Impact factor: 5.226

3.  Reactivation of type 1 herpes simplex virus and varicella zoster virus in an immunosuppressed patient with acute peripheral facial weakness.

Authors:  Jean Tsai; Randall J Cohrs; Maria A Nagel; Ravi Mahalingam; D Scott Schmid; Alexander Choe; Don Gilden
Journal:  J Neurol Sci       Date:  2011-09-15       Impact factor: 3.181

4.  Search for varicella zoster virus DNA in saliva of healthy individuals aged 20-59 years.

Authors:  Marius Birlea; Randall J Cohrs; Nathan Bos; Satish K Mehta; Duane L Pierson; Don Gilden
Journal:  J Med Virol       Date:  2013-11-06       Impact factor: 2.327

Review 5.  Efficacy of live zoster vaccine in preventing zoster and postherpetic neuralgia.

Authors:  D Gilden
Journal:  J Intern Med       Date:  2011-02-23       Impact factor: 8.989

6.  Serological detection of human papillomavirus type 16 infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.

Authors:  Michael J Silverberg; Michael F Schneider; Barbara Silver; Kathryn M Anastos; Robert D Burk; Howard Minkoff; Joel Palefsky; Alexandra M Levine; Raphael P Viscidi
Journal:  Clin Vaccine Immunol       Date:  2006-04

7.  Clinical and molecular aspects of varicella zoster virus infection.

Authors:  Don Gilden; Maria A Nagel; Ravi Mahalingam; Niklaus H Mueller; Elizabeth A Brazeau; Subbiah Pugazhenthi; Randall J Cohrs
Journal:  Future Neurol       Date:  2009-01-01

Review 8.  Varicella zoster virus infection.

Authors:  Anne A Gershon; Judith Breuer; Jeffrey I Cohen; Randall J Cohrs; Michael D Gershon; Don Gilden; Charles Grose; Sophie Hambleton; Peter G E Kennedy; Michael N Oxman; Jane F Seward; Koichi Yamanishi
Journal:  Nat Rev Dis Primers       Date:  2015-07-02       Impact factor: 52.329

Review 9.  Varicella-zoster.

Authors:  Don Gilden; Maria A Nagel; Randall J Cohrs
Journal:  Handb Clin Neurol       Date:  2014

Review 10.  Varicella zoster virus infection: clinical features, molecular pathogenesis of disease, and latency.

Authors:  Niklaus H Mueller; Donald H Gilden; Randall J Cohrs; Ravi Mahalingam; Maria A Nagel
Journal:  Neurol Clin       Date:  2008-08       Impact factor: 3.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.